ArticleJACC. Case reports2026
Acute Myocardial Infarction in an Intermediate-Risk Patient: Implications for Cardiovascular Risk Stratification.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiovascular risk stratification is essential and informative for long-term prognostication. However, it is often limited by heterogeneous patient profiles. CASE SUMMARY: An asymptomatic 76-year-old man with a history of multiple myeloma in remission presented for cardiovascular risk assessment. Despite intermediate-risk classification of atherosclerotic cardiovascular disease using risk stratification scores, the coronary artery calcium score (73 Agatston units) was used to guide decision-making regarding initiation of lipid-lowering therapy. However, before therapy initiation, the patient experienced an ST-segment elevation myocardial infarction. DISCUSSION: Cardiovascular risk stratification tools serve an important role in evaluating patient risk and facilitating shared decision-making in clinical management. Nonetheless, these tools present certain limitations in predicting comprehensive risk outcomes, especially when used independently. KEY TAKEAWAYS: This case highlights the intricacies associated with cardiovascular risk stratification tools and reinforces the importance of using a multimodal assessment strategy to inform the initiation of preventive therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.